ExodusPoint Capital Management, LP
Position in ABEO — Abeona Therapeutics Inc.
CIK 1736225
NEW YORK, NY
Position in ABEO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,312,168
+$761,379 QoQ
Shares Held
212,325
+72.7% QoQ
Ownership
0.371%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 125 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. ABEO ranks #50 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in ABEO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,312,168 | 212,325 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $550,789 | 122,944 | Shares | Sole | 2026-05-14 | |
| 2025-03-31 | $116,186 | 24,409 | Shares | Sole | 2025-05-14 | |
| 2023-03-31 | $340,805 | 120,853 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $290,046 | 94,171 | Shares | Sole | 2023-02-13 | |
| 2021-09-30 | $18,552 | 16,565 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $159,408 | 102,185 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $37,810 | 20,112 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||